openai
PublishedOctober 20, 2026 at 12:00 AM
OpenAI acquires Orchestra Bio
Publisher summary· verbatim
OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
Stay posted· Newsletter
Three short emails a week: Monday, Wednesday and Friday. Top movers, new models and the most-referenced story.
Your email is used only to send The Bubble Brief. Privacy policy
Discussion
No replies yet. Be first.
The Bubble Brief
MON · WED · FRIRead AI insights every Monday, Wednesday and Friday — top movers, new models, story of the week.
Your email is used only to send The Bubble Brief. Privacy policy
Originally published on openai ↗